Evidence map›Paper›PMID 31286894›Full record

ArticleBMC neurology2019

Application of artificial neural network model in diagnosis of Alzheimer's disease.

Naibo Wang, Jinghua Chen, Hui Xiao, Lei Wu, Han Jiang, Yueping Zhou

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Naibo WangJiangxi Province Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, 330006, People's Republic of China.
Jinghua ChenJiangxi Province Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, 330006, People's Republic of China.
Hui XiaoJiangxi Province Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, 330006, People's Republic of China.
Lei WuJiangxi Province Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, 330006, People's Republic of China. wulei2060@aliyun.com.
Han JiangSecond Affiliated Hospital, Nanchang University, Nanchang, China. jhan3939@sina.com.
Yueping ZhouJiangxi Province Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, 330006, People's Republic of China.
Nanchang University · CN

Funding

National Natural Science Foundation of China 81560550National Natural Science Foundation of China (CN) 81260441
6 · The paper itself

Abstract

backgroundAlzheimer's disease has become a public health crisis globally due to its increasing incidence. The purpose of this study was to establish an early warning model using artificial neural network (ANN) for early diagnosis of AD and to explore early sensitive markers for AD.

methodsA population based nested case-control study design was used. 89 new AD cases with good compliance who were willing to provide urine and blood specimen were selected from the cohort of 2482 community-dwelling elderly aged 60 years and over from 2013 to 2016. For each case, two controls living nearby were identified. Biomarkers for AD in urine and blood, neuropsychological functions and epidemiological parameters were included to analyze potential risk factors of AD. Compared with logistic regression, k-Nearest Neighbor (kNN) and support vector machine (SVM) model, back-propagation neural network of three-layer topology structures was applied to develop the early warning model. The performance of all models were measured by sensitivity, specificity, accuracy, positive prognostic value (PPV), negative prognostic value (NPV), the area under curve (AUC), and were validated using bootstrap resampling.

resultsThe average age of AD group was about 5 years older than the non-AD controls (P < 0.001). Patients with AD included a significantly larger proportion of subjects with family history of dementia, compared with non-AD group. After adjusting for age and gender, the concentrations of urinary AD7c-NTP and aluminum in blood were significantly higher in AD group than non-AD group (2.01 ± 1.06 vs 1.03 ± 0.43, 1.74 ± 0.62 vs 1.24 ± 0.41 respectively), but the concentration of Selenium in AD group (2.26 ± 0.59) was significantly lower than that in non-AD group (2.61 ± 1.07). All the models were established using 18 variables that were significantly different between AD patients and controls as independent variables. The ANN model outperformed the other classifiers. The AUC for this ANN was 0.897 and the model obtained the accuracy of 92.13%, the sensitivity of 87.28% and the specificity of 94.74% on the average.

conclusionsIncreased risk of AD may be associated with higher age among senior citizens in urban communities. Urinary AD7c-NTP is clinically valuable for the early diagnosis. The established ANN model obtained a high accuracy and diagnostic efficiency, which could be a low-cost practicable tool for the screening and diagnosis of AD for citizens.

Indexed as

Neural Networks, ComputerAgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesArea Under CurveBiomarkersCase-Control StudiesEarly DiagnosisFemaleHumansMaleNerve Tissue ProteinsPeptide FragmentsSensitivity and SpecificityTrace ElementsAD7c-NTPAD7c-NTP protein, humanAmyloid beta-Peptidesamyloid beta-protein (1-42)BiomarkersNerve Tissue ProteinsPeptide FragmentsTrace ElementsAlzheimer’s diseaseArtificial neural networkEarly diagnosisRisk factorsUrban communities

Identifiers

PMID31286894
PMCPMC6613238
OpenAlexW2953679709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.